A need for standardized definitions for clinical studies of Pneumocystis

Journal of Eukaryotic Microbiology

Volumn 53, Issue SUPPL. 1, 2006, Pages

  Miller, Robert F ^a,c   Huang, Laurence ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; DIHYDROPTEROATE SYNTHASE; SULFANILAMIDE DERIVATIVE;

PNEUMONIA;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MEDICAL RESEARCH; PNEUMOCYSTIS; PNEUMOCYSTOSIS; STANDARD;

ANTIFUNGAL AGENTS; BIOMEDICAL RESEARCH; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE, FUNGAL; HUMANS; PNEUMOCYSTIS; PNEUMOCYSTIS INFECTIONS; SULFANILAMIDES;

PNEUMOCYSTIS;

EID: 33751352746     PISSN: 10665234     EISSN: 15507408     Source Type: Journal    
DOI: 10.1111/j.1550-7408.2006.00183.x     Document Type: Conference Paper

References (20)

1. Beard, C. B., Roux, P., Hauser, P. M., Kovacs, J. A., Unnasch, T. R. & Lundgren, B. 2004. Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis., 10:1729-1735.
2. Cisneros, J. M., Munoz, P., Torre-Cisneros, J., Gurgui, M., Rodriguez-Hernandez, M. J., Aguado, J. M. & Echaniz, A. 1998. Pneumonia after heart transplantation: a multi-institutional study. Spanish transplantation infection group. Clin. Infect. Dis., 27:324-331.
3. Crothers, K., Beard, C. B., Turner, J., Groner, G., Fox, M., Morris, A., Eiser, S. & Huang, L. 2005. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS, 19:801-805.
4. Fetic, E., Gajic, O., Limper, A. H. & Aksamit, T. R. 2005. Acute respiratory failure due to Pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest, 128:573-379.
5. Helweg-Larsen, J., Benfield, T. L., Eugen-Olsen, J. & Lundgren, J. D. 1999. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet, 54:1347-1351.
6. Huang, L., Morris, A. M. & Beard, C. B. 2001. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation. J. Eukaryot. Microbiol., 48:180S-181S.
7. Kazanjian, P., Armstrong, W., Hossler, P. A., Burman, W., Richardson, J., Lee, C. H., Crane, L., Katz, J. & Meshnick, S. R. 2000. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J. Infect. Dis., 182:551-557.
8. Leoung, G., Mills, J., Hopewell, P. C., Hughes, W. & Wofsy, C. 1986. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med., 105:45-48.
9. Linssen, C. F. M., Jacobs, J. A., Beckers, P., Templeton, K. E., Bakkers, J., Kuijper, E. J., Melchers, W. J. G., Drent, M. & Vink, C. 2006. Interlaboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samples. J. Med. Microbiol., 55:1229-1235.
10. Maskell, N., Waine, D. J., Lindley, A., Pepperell, J. C. T., Wakefield, A. E., Miller, R. F. & Davies, R. J. 2003. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax, 58:594-597.
11. Medina, I., Mills, J., Leoung, G., Hopewell, P. C., Lee, B., Modin, G., Benowitz, N. & Wofsy, C. B. 1990. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprimdapsone. N. Engl. J. Med., 323:776-782.
12. Miller, R. F., Millar, A. B., Weller, I. V. D. & Semple, S. J. G. 1989. Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Thorax, 44:559-564.
13. Morris, A., Lundgren, J. D., Masur, H., Walzer, P. D., Hanson, D. L., Frederick, T., Huang, L., Beard, C. B. & Kaplan, J. E. 2004a. Current epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis., 10:1713-1720.
14. Morris, A., Kingsley, L. A., Groner, G., Lebedeva, I. P., Beard, C. B. & Norris, K. A. 2004b. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS, 18:793-798.
15. Morris, A., Sciurba, F. C., Lebedeva, I. P., Githaiga, A., Elliott, W. M., Hogg, J. C., Huang, L. & Norris, K. A. 2004c. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am. J. Respir. Crit. Care Med., 170:408-413.
16. Navin, T. R., Beard, C. B., Huang, L., del Rio, C., Lee, S., Pieniazek, N. J., Carter, J. L., Le, T., Hightower, A. & Rimland, D. 2001. Effect of mutations on in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet, 358:545-549.
17. Nevez, G., Raccurt, C., Jounieaux, V., Dei-Cas, E. & Mazars, E. 1999. Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients. AIDS, 13:535-536.
18. Redhead, S. A., Cushion, M. T., Frenkel, J. K. & Stringer, J. R. 2006. Pneumocystis and Trypanosoma cruzi: nomenclature and typifications. J. Eukaryot. Microbiol., 53:2-11.
19. Sattler, F., Frame, P., Davis, R., Nichols, L., Shelton, B., Akil, B., Baughman, R., Hughlett, C., Weiss, W., Boylen, C. T., van der Horst, C., Black, J., Powderly, W., Steigbel, R. T., Leedom, J. M., Masur, H. & Feinberg, J.AIDS Clinical Trials Group 029/031 Research Team. 1994. Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group protocol 029/031. J. Infect. Dis., 170:165-172.
20. Wakefield, A. E., Lindley, A. R., Ambrose, H. E., Denis, C-M. & Miller, R. F. 2003. Limited asymptomatic carriage of Pneumocystis jiroveci in HIV-infected patients. J. Infect. Dis., 187:901-908.